I note that the glucose tolerance tests used during the Newcsastle diet did not do this priming. However they used an insulin clamp technique, so this may get round the need to pre-prime. I have my doubts,
It is a technique where the glucose is intravenously applied rather than orally. From what I have read in studies that use it the effect is not as severe as the oral hit, so the insulin stimulus is not so strong.Insulin clamp technique??? What is that?
The technique is common to mice and other animal studies and works well in the lab, It is uncommon to use it in human studies. My searches only turned up 3 instances of human trials. Newcastle Diet, a chinese study and a study in America. Two of these studies reported problems with interpreting the results when used for T1D diagnosis and c-peptide testing, and i discovered a systemic error when Roy Taylor used it in the ND trials,Here you go
https://pubmed.ncbi.nlm.nih.gov/22126863/
It was the method that Kraft used for his decades long work establishing the widespread extent of hyperinsulinaemia amongst supposedly non-prediabetics in the US population, whilst simultaneously establishing the links between hyperinsulinaemia and heart disease. And tinnitus.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708305/
I thought it was the "gold standard" but too complex for normal insulin measurement.The technique is common to mice and other animal studies and works well in the lab, It is uncommon to use it in human studies. My searches only turned up 3 instances of human trials. Newcastle Diet, a chinese study and a study in America. Two of these studies reported problems with interpreting the results when used for T1D diagnosis and c-peptide testing, and i discovered a systemic error when Roy Taylor used it in the ND trials,
It seems that using a drip or infusion bypasses an essential part of the insulin response and that an important enzyme or two is not triggered (amylase?) so possibly introducing error especially when considering the first phase insulin response seen in humans, It may be responsible for some misdiagnosis in TOFI undividuals so the OGTT is perhaps a better test. C- peptide is normally assayed from a blood draw or urine test, so does not use this technique in humans.
Many of us here have an inherent mistrust of 'mice studies'. This is another aspect supporting that view,
It is a test on beta cell output and the ability of that to clear excess glucose, , but does not measure the complete metabolic pathway that is involved in human diabetes management, It does not aid in diagnosis of T1/T2 for instance. It certainly does not appear to trigger the first insulin response to carbohydrate since this uses mechanisms that are different from the basal second stage. It is not all just about the blood glucose but also the ability to trigger and control other enzymes involved in metabolism.I thought it was the "gold standard" but too complex for normal insulin measurement.
In human clinical trials, manual glucose clamps as well as the more modern method of automated glucose clamp find common use.
https://en.wikipedia.org/wiki/Glucose_clamp_technique
It is a test on beta cell output and the ability of that to clear excess glucose, , but does not measure the complete metabolic pathway that is involved in human diabetes management, It does not aid in diagnosis of T1/T2 for instance. It certainly does not appear to trigger the first insulin response to carbohydrate since this uses mechanisms that are different from the basal second stage. It is not all just about the blood glucose but also the ability to trigger and control other enzymes involved in metabolism.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?